Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 36 min ago
Peer-reviewedCC BYFrontiers in Aging

Aging and vaccines: impact of immunosenescence and inflammaging in vaccine response

  1. 1Department of Microbiology, Immunology and Infectious Diseases, College of Medicine and Health Sciences, Arabian Gulf University, Manama

Abstract

Historically, effective vaccination has saved millions of lives and made an enormous contribution to addressing global public health threats. However, aging is an inevitable factor that negatively affects vaccine effectiveness and efficacy. With age, humans develop dysregulation of innate immune pathways, increased levels of proinflammatory markers, thymic involution, declines in T- and B-cell numbers and function, dysregulated metabolism, and epigenetic alterations. Immunosenescence, the gradual deterioration of host immunity with age, plays a critical role in susceptibility to infection, disease progression, and vaccine efficacy. Immunosenescence is often accompanied by inflammaging, an age-related increase in proinflammatory cytokine and chemokine levels. This multifactorial and dynamic process can lead to poor vaccine responses, potentially resulting in higher morbidity and mortality in older adults. Therefore, research focused on understanding the impact of immunosenescence and inflammaging on vaccine response will undoubtedly help optimize vaccine delivery among elderly individuals. In this review, we summarize the most recent knowledge on the multifactorial effects of age-induced immunosenescence and inflammaging and their role in vaccine efficacy against respiratory tract infections. The review further discusses strategic approaches such as IL-7 therapy, senolytic therapy, increasing telomerase activity, use of mTOR inhibitors, B cell therapy, development of broader vaccines and new adjuvants, and positive lifestyle changes, to enhance vaccine immunogenicity and efficacy in older adults. This could provide theoretical insights to improve vaccine effectiveness in the elderly and help address major global health issues.

Related

  1. Effects of exercise and physical activity on circulating inflammaging- and immunosenescence-related biomarkers in older adults and adults with chronic diseases: an umbrella review
    Guangwei Chai, Jinhong Xue, Bin Xie
    Frontiers in immunologyPeer-reviewedCC BYFull textImmunologyEurope PMC
  2. Integrative reanalysis of public intracellular and vaccine-challenge transcriptomes, informed by single-cell and metabolomic atlases, refines antigen prioritisation for next-generation veterinary Brucella vaccines
    Y. Zhao, H. Cheng, S. Zhou +4
    bioRxivPreprintCC BY-NCFull textImmunologybioRxiv
  3. Short-term adverse events following modified vaccinia Ankara–Bavarian Nordic (MVA-BN) mpox vaccine with and without concomitant vaccines, Australia, 2022 to 2023
    Thuy Nguyen, Kristine Macartney, Nicholas Wood +2
    EurosurveillancePeer-reviewedCC BY 4.0Full textMicrobiologyPMC
  4. Steering the immune response: cancer vaccines and the next era of cancer immunotherapy
    Lisa H Butterfield, James L Gulley
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BY-NC 4.0Full textImmunologyDOAJPMC
  5. Limited cross strain CMV protection by a bivalent (gB/pp65) vaccine is based on an impaired gB antibody response and evasion of pp65 cell mediated immunity
    K. Yeon Choi, Yushu Qin, Nadia El-Hamdi +1
    bioRxivPreprintAll rights reservedFull textMicrobiologybioRxivPMC
BibTeX
@article{albaloshi2026aging,
  title = {{Aging and vaccines: impact of immunosenescence and inflammaging in vaccine response}},
  author = {Jalnar Albaloshi and Alhussain Alnakhli and Lamin B. Cham},
  journal = {Frontiers in Aging},
  year = {2026},
  month = jul,
  doi = {10.3389/fragi.2026.1797166},
  url = {https://doi.org/10.3389/fragi.2026.1797166},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Aging and vaccines: impact of immunosenescence and inflammaging in vaccine response
AU  - Jalnar Albaloshi
AU  - Alhussain Alnakhli
AU  - Lamin B. Cham
PY  - 2026
DA  - 2026/07/03
JO  - Frontiers in Aging
DO  - 10.3389/fragi.2026.1797166
UR  - https://doi.org/10.3389/fragi.2026.1797166
AB  - Historically, effective vaccination has saved millions of lives and made an enormous contribution to addressing global public health threats. However, aging is an inevitable factor that negatively affects vaccine effectiveness and efficacy. With age, humans develop dysregulation of innate immune pathways, increased levels of proinflammatory markers, thymic involution, declines in T- and B-cell numbers and function, dysregulated metabolism, and epigenetic alterations. Immunosenescence, the gradual deterioration of host immunity with age, plays a critical role in susceptibility to infection, disease progression, and vaccine efficacy. Immunosenescence is often accompanied by inflammaging, an age-related increase in proinflammatory cytokine and chemokine levels. This multifactorial and dynamic process can lead to poor vaccine responses, potentially resulting in higher morbidity and mortality in older adults. Therefore, research focused on understanding the impact of immunosenescence and inflammaging on vaccine response will undoubtedly help optimize vaccine delivery among elderly individuals. In this review, we summarize the most recent knowledge on the multifactorial effects of age-induced immunosenescence and inflammaging and their role in vaccine efficacy against respiratory tract infections. The review further discusses strategic approaches such as IL-7 therapy, senolytic therapy, increasing telomerase activity, use of mTOR inhibitors, B cell therapy, development of broader vaccines and new adjuvants, and positive lifestyle changes, to enhance vaccine immunogenicity and efficacy in older adults. This could provide theoretical insights to improve vaccine effectiveness in the elderly and help address major global health issues.
SN  - 2673-6217
ER  -